Fairmount Helps Medpace Score Major Deal with Cinven

February 24, 2014 – European private equity firm, Cinven, today announced a majority investment in Medpace, Inc., a leading contract research organization (‘CRO’), for a total consideration of US $915 million plus certain cash inflows relating to the period of ownership, acquired from CCMP Capital Advisors, LLC. Medpace is a global CRO business providing management […]

Fairmount Partners Assists Covance, Inc. (NYSE: CVD) in Sale of Its Genomics Laboratory to Laboratory Corporation of America Holdings (NYSE: LH)

PRINCETON, NJ – February 4, 2014 – On January 31, 2014, Covance, Inc. sold its high-complexity genomics laboratory, located in Seattle, Washington, to Laboratory Corporation of America Holdings, and entered into a five year services agreement, pursuant to which Covance will collaborate with LabCorp to continue to offer these services to its clients.  Covance expects […]